Clinical Trials | February 14, 2024
Roche launches three new Factor Xa inhibitor coagulation tests
The new tests can support clinical decision making when prescribing direct oral anticoagulants for stroke prevention
The new tests can support clinical decision making when prescribing direct oral anticoagulants for stroke prevention
The new campus has been designed as an employee-centred experience and ecosystem zone
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
Almost 300 million people globally have chronic hepatitis B
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators
Columvi is part of Roche's industry-leading portfolio of T-cell engaging bispecific antibodies in non-Hodgkin lymphoma, which also includes the recently approved Lunsumio to treat follicular lymphoma
navify Sample Tracking is part of the navify Diagnostics portfolio, a set of digital solutions enabling labs to drive end-to-end operational excellence across care settings.
Subscribe To Our Newsletter & Stay Updated
